4//SEC Filing
AEOLUS PHARMACEUTICALS, INC. 4
Accession 0001102624-16-002067
CIK 0001261734operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:24 PM ET
Size
5.5 KB
Accession
0001102624-16-002067
Insider Transaction Report
Form 4
Kaye Mitchell D
Director
Transactions
- Award
Non-qualified Stock Option (right to buy)
2013-10-01+75,000→ 75,000 totalExercise: $0.26Exp: 2023-10-01→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.
Documents
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261734
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:24 PM ET
- Size
- 5.5 KB